Artivion, Inc. – NYSE:CRY

Artivion stock price today

$17.88
+17.88
Financial Health
0
1
2
3
4
5
6
7
8
9

Artivion stock price monthly change

-100.00%
month

Artivion stock price quarterly change

-100.00%
quarter

Artivion stock price yearly change

-100.00%
year

Artivion key metrics

Market Cap
725.14M
Enterprise value
1.00B
P/E
425.71
EV/Sales
3.37
EV/EBITDA
38.68
Price/Sales
2.34
Price/Book
2.32
PEG ratio
33.19
EPS
-0.24
Revenue
368.20M
EBITDA
32.55M
Income
-9.62M
Revenue Q/Q
17.06%
Revenue Y/Y
15.13%
Profit margin
-4.96%
Oper. margin
-2.61%
Gross margin
66.09%
EBIT margin
-2.61%
EBITDA margin
8.84%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Artivion stock price history

Artivion stock forecast

Artivion financial statements

Artivion, Inc. (NYSE:CRY): Profit margin
Jun 2023 89.25M -3.38M -3.79%
Sep 2023 87.85M -9.80M -11.16%
Dec 2023 93.67M -3.97M -4.24%
Mar 2024 97.43M 7.53M 7.73%
Artivion, Inc. (NYSE:CRY): Earnings per share (EPS)
2021-04-29 -0.09 -0.08
2021-07-29 -0.05 -0.06
2021-11-04 0.05 0.26
Artivion, Inc. (NYSE:CRY): Debt to assets
Jun 2023 777861000 495.35M 63.68%
Sep 2023 774787000 502.81M 64.9%
Dec 2023 792397000 510.61M 64.44%
Mar 2024 784007000 489.02M 62.37%
Artivion, Inc. (NYSE:CRY): Cash Flow
Jun 2023 6.90M 7.07M 2.23M
Sep 2023 7.23M -2.06M -909K
Dec 2023 10.58M -2.66M -1.38M
Mar 2024 -15.49M -3.61M 10.73M

Artivion alternative data

Artivion, Inc. (NYSE:CRY): Employee count
Aug 2023 1,200
Sep 2023 1,200
Oct 2023 1,200
Nov 2023 1,200
Dec 2023 1,200
Jan 2024 1,200
Feb 2024 1,200
Mar 2024 1,200
Apr 2024 1,200
May 2024 1,200
Jun 2024 1,200
Jul 2024 1,200

Artivion other data

Artivion, Inc. (NYSE:CRY): Insider trades (number of shares)
Period Buy Sel
Feb 2021 0 14394
Mar 2021 0 15312
Apr 2021 0 26312
May 2021 0 69917
Aug 2021 0 9045
Nov 2021 15600 0
Dec 2021 0 2500
Transaction Date Insider Security Shares Price per share Total value Source
Sale
HORTON AMY officer: VP, Chief Accounting O..
Common Stock 2,500 $18.57 $46,423
Purchase
SEMEDO ANTHONY B. director
Common Stock 15,000 $17.36 $260,400
Purchase
DAVIS JOHN E officer: Senior V.. Common Stock 600 $17.33 $10,398
Sale
HOLLOWAY JEAN F officer: SVP, Gen.. Common Stock 663 $26.5 $17,566
Sale
MCCALL RONALD D director
Common Stock 5,667 $25.63 $145,268
Sale
MAIER DENNIS B officer: Vice President, Operat..
Common Stock 2,715 $25.64 $69,613
Sale
MCCALL RONALD D director
Common Stock 5,783 $29.55 $170,888
Sale
DAVIS JOHN E officer: Senior V.. Common Stock 12,739 $28.53 $363,456
Option
DAVIS JOHN E officer: Senior V.. Common Stock 5,402 $26.24 $141,748
Option
DAVIS JOHN E officer: Senior V.. Stock Options (Right To buy) 5,402 $26.24 $141,748
Patent
Application
Filling date: 22 Mar 2019 Issue date: 26 Sep 2019
Application
Filling date: 5 Jan 2017 Issue date: 26 Sep 2019
Insider Compensation
Mr. James Patrick Mackin (1967) Chairman, Pres & Chief Executive Officer $1,090,000
Mr. David Ashley Lee CPA, CPA (1965) Executive Vice President, Chief Operating Officer & Chief Financial Officer
$579,080
Ms. Jean F. Holloway Esq. (1957) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. $476,260
Mr. John E. Davis (1965) Senior Vice President of Global Sales & Marketing $436,390
Saturday, 10 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
prnewswire.com
Monday, 5 August 2024
prnewswire.com
Thursday, 25 July 2024
prnewswire.com
Monday, 1 July 2024
prnewswire.com
Friday, 21 June 2024
seekingalpha.com
Thursday, 18 January 2024
prnewswire.com
Wednesday, 17 November 2021
GuruFocus
Monday, 8 November 2021
Zacks Investment Research
Sunday, 7 November 2021
Seeking Alpha
Thursday, 4 November 2021
Benzinga
Wednesday, 22 September 2021
PRNewsWire
Tuesday, 31 August 2021
PRNewsWire
  • What's the price of Artivion stock today?

    One share of Artivion stock can currently be purchased for approximately $17.88.

  • When is Artivion's next earnings date?

    Unfortunately, Artivion's (CRY) next earnings date is currently unknown.

  • Does Artivion pay dividends?

    No, Artivion does not pay dividends.

  • How much money does Artivion make?

    Artivion has a market capitalization of 725.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.82% to 354M US dollars. Artivion made a loss 30.69M US dollars in net income (profit) last year or $0.26 on an earnings per share basis.

  • What is Artivion's stock symbol?

    Artivion, Inc. is traded on the NYSE under the ticker symbol "CRY".

  • What is Artivion's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Artivion?

    Shares of Artivion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Artivion's key executives?

    Artivion's management team includes the following people:

    • Mr. James Patrick Mackin Chairman, Pres & Chief Executive Officer(age: 58, pay: $1,090,000)
    • Mr. David Ashley Lee CPA, CPA Executive Vice President, Chief Operating Officer & Chief Financial Officer(age: 60, pay: $579,080)
    • Ms. Jean F. Holloway Esq. Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.(age: 68, pay: $476,260)
    • Mr. John E. Davis Senior Vice President of Global Sales & Marketing(age: 60, pay: $436,390)
  • How many employees does Artivion have?

    As Jul 2024, Artivion employs 1,200 workers.

  • When Artivion went public?

    Artivion, Inc. is publicly traded company for more then 32 years since IPO on 12 Feb 1993.

  • What is Artivion's official website?

    The official website for Artivion is artivion.com.

  • Where are Artivion's headquarters?

    Artivion is headquartered at 1655 Roberts Blvd NW, Kennesaw, GEORGIA.

  • How can i contact Artivion?

    Artivion's mailing address is 1655 Roberts Blvd NW, Kennesaw, GEORGIA and company can be reached via phone at +1 770 419 3355.

Artivion company profile:

Artivion, Inc.

artivion.com
Exchange:

NYSE

Full time employees:

1,200

Industry:

Medical - Devices

Sector:

Healthcare

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

1655 Roberts Blvd NW
Kennesaw, GEORGIA 30144

CIK: 0000784199
ISIN: US2289031005
CUSIP: 228903100